Melanovus Oncology (Assets) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Melanovus Oncology (Assets) General Information

Description

Seven pre-clinical compounds. These compounds are useful for the treatment of melanoma and other cancers.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Other Pharmaceuticals and Biotechnology
Biotechnology
Primary Office
  • FL
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Melanovus Oncology (Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Melanovus Oncology (Assets)‘s full profile, request access.

Request a free trial

Melanovus Oncology (Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Melanovus Oncology (Assets)‘s full profile, request access.

Request a free trial